We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HPQ:NYSEHP Inc. Analysis

Data as of 2026-09-05 - not real-time

$32.64

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

HP Inc. trades at $32.64, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 26.8%. Relative strength is 66.4 — approaching overbought — and the MACD signal is bullish. Watch $26.73 as support and $32.78 as the nearer resistance level.
The shares look fair, trading on 12.2 times earnings below a sector average of 33.2. Analyst price targets sit 9.8% below the current price. Revenue is growing at 12.5% on a 4.1% profit margin. The 3.76% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 51.9%, a beta of 0.74 and a maximum drawdown of 38.0%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.

Top Market Events

What Happened? Shares of personal computing and printing company HP NYSE:HPQ fell 5.8% in the afternoon session after...HP Inc. NYSE:HPQ is one of the best dividend stocks to invest in, according to Jim Simons’ Renaissance Technologies,...PALO ALTO, Calif., Aug. 06, 2026 GLOBE NEWSWIRE -- HP Inc. NYSE: HPQ will present a live audio webcast of a conference...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 22.87
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 12.2 versus sector average of 33.2
  • Trading above the 200-day average of 22.87

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 12.2 versus sector average of 33.2
  • Analyst targets imply -9.8% versus the current price
  • Revenue growth of +12.5%

Key Metrics & Analysis

Financial Health

Revenue Growth12.50%
Profit Margin4.14%
P/E Ratio12.2
ROA5.63%
P/B Ratio-320.0
Op. Cash Flow$4.7B
Free Cash Flow$3.4B
Industry P/E33.2

Technical Analysis

TrendBullish
RSI66.4
Support$26.73
Resistance$32.78
MA 20$30.24
MA 50$27.21
MA 200$22.87
MACDBullish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

Fair Value$73.33
Target Price$29.46
Upside/Downside-9.75%
GradeFair
TypeValue
Dividend Yield3.76%

Risk Assessment

Beta0.74
Volatility51.86%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.